Tricida Inc
Change company Symbol lookup
Select an option...
TCDAQ Tricida Inc
HROWL HARROW HEALTH 8 625 SNR NTS
MLTX MoonLake Immunotherapeutics
TRTN Triton International Ltd
PAYA Paya Holdings Inc
MA Mastercard Inc
MWRK MetaWorks Platforms Inc
NSRGY Nestle SA
MIN MFS? Intermediate Income Fund
MCO Moody's Corp
Go

Health Care : Pharmaceuticals | Small Cap Value

Tricida, Inc. is a pharmaceutical company, which is focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101). TRC101, is a non-absorbed, orally administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal (GI), tract. Its Veverimer, is a low-swelling, spherical polymer bead that is approximately 100 micrometers in diameter, which is a single, molecular weight, crosslinked polyamine molecule. It is conducting renal outcomes clinical trial, VALOR-CKD (TRCA-303), to determine if veverimer slows CKD progression in patients with metabolic acidosis associated with CKD. The Company's VALOR-CKD trial is a randomized, double-blind, placebo-controlled, time-to-event trial.

Closing Price: $0.0491

Day's Change: -0.0029 (-5.58%)

Bid: --

Ask: --

B/A Size: --

Day's High: 0.0529

Day's Low: 0.0427

Volume (Light) Volume: 5,327,152 10-day average volume: 23,112,362: 5,327,152

Hasbro Inc. Stock Rises Tuesday, Outperforms Market

5:05 pm ET November 29, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Hasbro Inc. (HAS) inched 0.65% higher to $62.17 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.01% to 33,852.53 and the S&P 500 Index falling 0.16% to 3,957.63. The stock's rise snapped a two-day losing streak. Hasbro Inc. closed $43.56 below its 52-week high ($105.73), which the company achieved on January 5th.

Trading volume (1.0 M) remained 545,717 below its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 29, 2022.

(END) Dow Jones Newswires

November 29, 2022 17:05 ET (22:05 GMT)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and